Albert David Ltd.

Financial

	Albert David	Jenburkt Pharma	Medico Remedies
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.54 %	0.87 %	n/a
Financials
5 yr Average ROE	12.32 %	18.48 %	11.79 %
5yr average Equity Multiplier	1.67	1.2	2.18
5yr Average Asset Turnover Ratio	0.67	0.95	1.48
5yr Avg Net Profit Margin	11.52 %	16.38 %	3.76 %
Price to Book	1.28	2.89	7.28
P/E	12.45	14.52	45.11
5yr Avg Cash Conversion Cycle	-59.38 Days	-16.2 Days	34.15 Days
Inventory Days	46.72 Days	26.89 Days	52.67 Days
Days Receivable	28.39 Days	46.84 Days	107.96 Days
Days Payable	118.01 Days	76.62 Days	136.18 Days
5yr Average Interest Coverage Ratio	90.39	75.84	9.64
5yr Avg ROCE	15.83 %	24.52 %	17.25 %
5yr Avg Operating Profit Margin	11.27 %	20.46 %	5.84 %
5 yr average Debt to Equity	0.01	0.03	0.3
5yr CAGR Net Profit	31.51 %	11.81 %	38.44 %
5yr Average Return on Assets	7.45 %	15.36 %	5.66 %
Shareholdings
Promoter Holding	62.24 %	46.68 %	63.79 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.28 %	0.95 %	-9.55 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Albert David	Jenburkt Pharma	Medico Remedies
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Dermatology 0 Traded Goods 0 Manufactured Goods 0	Product Wise Break-Up Pharmaceutical 0 Dermatology 0 Traded Goods 0 Manufactured Goods 0 Others 100	Product Wise Break-Up Pharmaceutical 0 Dermatology 0 Traded Goods 1.29 Manufactured Goods 97.59 Others 1.12
Location Wise Break-Up	Location Wise Break-Up India 92.79 Rest of the World 7.21 Outside India 0	Location Wise Break-Up Outside India 0 Rest of the World 14.1 India 85.66 Others 0.24	Location Wise Break-Up Outside India 84.62 Rest of the World 0 India 15.38
Dosage Form Break-Up	Dosage Form Break-Up LVP – Large volume Parenteral 27.77 Syrup 19.48 SVP – Small volume Parenteral 18.51 Tablet 15.8 Capsule 9.04 Ointment 8.18 Others 1.22	-	-
Customer Wise Break-Up	Customer Wise Break-Up Non Government 95.2 Government 4.8	-	-